4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-055353
SVP & Chief Medical Officer sold 100,000 shares at an average $24.14 ($2,413,640)
- SVP & Chief Medical Officer acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gergel Ivan P. · SVP & Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-09-29 | Exercise or conversion : show line 1 in the form | +43,296 | $11.04 | $477,988 | 84,871 | D |
| 2017-09-29 | Sale : show line 2 in the form | −43,296 | $24.04 | $1,040,836 | 41,575 | D |
| 2017-10-02 | Exercise or conversion : show line 3 in the form | +56,704 | $11.04 | $626,012 | 98,279 | D |
| 2017-10-02 | Sale : show line 4 in the form | −56,704 | $24.21 | $1,372,804 | 41,575 | D |
| Open-market sales · 100,000 sh · avg $24.14 · $2,413,640 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-09-29 | Exercise or conversion : show line 5 in the form Stock Option | −43,296 | 370,456 | D |
| 2017-10-02 | Exercise or conversion : show line 6 in the form Stock Option | −56,704 | 313,752 | D |
Loading xslF345X03/doc4.xml…